日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials

基于科学的临床试验联合用药安全风险评估方法框架

Patera, Andriani C; Maidment, Julie; Maroj, Brijesh; Mohamed, Ahmed; Twomey, Ken

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

一项针对晚期实体瘤患者的 I 期研究,旨在探索强效且选择性的 PI3Kβ/δ 抑制剂 AZD8186 的疗效。

Choudhury, Atish D; Higano, Celestia S; de Bono, Johann S; Cook, Natalie; Rathkopf, Dana E; Wisinski, Kari B; Martin-Liberal, Juan; Linch, Mark; Heath, Elisabeth I; Baird, Richard D; García-Carbacho, Javier; Quintela-Fandino, Miguel; Barry, Simon T; de Bruin, Elza C; Colebrook, Steve; Hawkins, George; Klinowska, Teresa; Maroj, Brijesh; Moorthy, Ganesh; Mortimer, Peter G; Moschetta, Michele; Nikolaou, Myria; Sainsbury, Liz; Shapiro, Geoffrey I; Siu, Lillian L; Hansen, Aaron R